Sarissa Biomedical Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.48M
Latest Deal Amount
  • Investors
  • 11

Sarissa Biomedical General Information

Description

Developer of a biosensor technology designed to identify people who are having a stroke. The company's technology is a point-of-care test that uses finger-prick blood samples which is then directed, monitored and controlled by software, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Unit 4B, Vanguard Centre
  • Sir William Lyons Road, Warwick University Science Park
  • Coventry CV4 7EZ
  • England, United Kingdom
+44 024 0000 0000

Sarissa Biomedical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarissa Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 20-May-2020 $1.48M 00.000 00.000 Completed Generating Revenue
11. Later Stage VC 08-Mar-2019 00000 00.00 00.000 Completed Generating Revenue
10. Grant 17-May-2018 00.000 00.000 Completed Generating Revenue
9. Later Stage VC 12-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
8. Later Stage VC 31-Mar-2017 00000 00.000 00.000 Completed Generating Revenue
7. Grant 04-Jul-2016 00000 00.000 Completed Generating Revenue
6. Later Stage VC 22-Dec-2015 00000 00.000 00.000 Completed Startup
5. Later Stage VC 12-Aug-2014 00000 00.000 00.000 Completed Startup
4. Later Stage VC 02-Dec-2010 $298K $1.2M 00.000 Completed Startup
3. Grant 01-Jan-2010 $898K Completed Startup
To view Sarissa Biomedical’s complete valuation and funding history, request access »

Sarissa Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 128,138 $0.012348 $2.73 $2.73 1x $2.73 12.88%
Preference 84,779 $0.012348 $2.73 $2.73 1x $2.73 8.52%
To view Sarissa Biomedical’s complete cap table history, request access »

Sarissa Biomedical Executive Team (5)

Name Title Board Seat Contact Info
Everard Mascarenhas Ph.D Chief Executive Officer & Board Member
Nicholas Dale Ph.D Co-Founder, Chief Technology Officer & Board Member
E. Llaudet Co-Founder & Research Assistant
Tim O'Connell Financial Director
To view Sarissa Biomedical’s complete executive team members history, request access »

Sarissa Biomedical Board Members (7)

Name Representing Role Since
Bruno Frenguelli Sarissa Biomedical Board Member 000 0000
Everard Mascarenhas Ph.D Sarissa Biomedical Chief Executive Officer & Board Member 000 0000
George Zajicek Self Board Member 000 0000
Nicholas Dale Ph.D Sarissa Biomedical Co-Founder, Chief Technology Officer & Board Member 000 0000
Quentin Compton-Bishop Sarissa Biomedical Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Sarissa Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sarissa Biomedical Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EarlyStage.nyc Fund Venture Capital Minority 000 0000 000000 0
Midlands Engine Investment Fund Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Small Business Research Initiative Government 000 0000 000000 0
University of Warwick Foundation Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »